| 注册
首页|期刊导航|中外医学研究|沙库巴曲缬沙坦联合螺内酯治疗慢性心力衰竭患者的效果

沙库巴曲缬沙坦联合螺内酯治疗慢性心力衰竭患者的效果

彭燕飞 宋初平 倪悦

中外医学研究2025,Vol.23Issue(13):28-32,5.
中外医学研究2025,Vol.23Issue(13):28-32,5.DOI:10.14033/j.cnki.cfmr.2025.13.008

沙库巴曲缬沙坦联合螺内酯治疗慢性心力衰竭患者的效果

Effect of Sacubitril Valsartan Combined with Spironolactone in the Treatment of Patients with Chronic Heart Failure

彭燕飞 1宋初平 1倪悦1

作者信息

  • 1. 溧阳市人民医院 江苏 溧阳 213300
  • 折叠

摘要

Abstract

Objective:To investigate the effect of Sacubitril Valsartan Combined with Spironolactone in the treatment of patients with chronic heart failure.Method:A prospective study was conducted to select 82 CHF patients admitted to Liyang People's Hospital from April 2022 to February 2024.They were randomly divided into two groups by random number table method,with 41 patients in each group.Both groups received routine anti heart failure and Spironolactone treatment,with the control group receiving Valsartan treatment and the observation group receiving Sacubitril Valsartan treatment.The efficacy after 12 weeks of treatment was evaluated.Result:The total clinical effective rate of the observation group was 90.24%,which was higher than 68.29%of the control group,and the difference was statistically significant(P<0.05).After treatment,the left ventricular ejection fraction in the observation group was higher than that in the control group,and the left ventricular end diastolic diameter,left ventricular end systolic thickness,end diastolic interventricular septum thickness,end diastolic left ventricular posterior wall thickness,left ventricular mass index,serum amino terminal brain natriuretic peptide precursor(NT-proBNP)and aldosterone levels,Minnesota Heart failure quality of life scale(MLHFQ)score were lower than those in the control group,the incidence of major adverse cardiovascular events(MACE)was lower than that in the control group,and the differences were statistically significant(P<0.05).There was no total significant difference in the incidence of adverse reactions in the two groups(P>0.05).Conclusion:The combination of Sacubitril Valsartan combined with Spironolactone can effectively inhibit left ventricular remodeling in CHF patients,regulate serum NT-proBNP levels,improve cardiac function and quality of life,and reduce the occurrence of MACE.

关键词

慢性心力衰竭/沙库巴曲缬沙坦/螺内酯/左心室重构/心功能/生活质量

Key words

Chronic heart failure/Sacubitril Valsartan/Spironolactone/Left ventricular remodeling/Heart function/Quality of life

引用本文复制引用

彭燕飞,宋初平,倪悦..沙库巴曲缬沙坦联合螺内酯治疗慢性心力衰竭患者的效果[J].中外医学研究,2025,23(13):28-32,5.

中外医学研究

1674-6805

访问量0
|
下载量0
段落导航相关论文